News | August 21, 2023
Venus Remedies launches its flagship R&D drug Elores in Oman
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
The citizens of Oman will soon have a coordination center that will provide end to end services for healthcare facilities of Jaslok.
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
The pharma companies will bring quality products at competitive prices to consumers in Oman and help bring down the cost of healthcare
In this role, Romanelli will have P&L responsibility for Merck’s US $22 billion international human health business and lead a team of 14,000 colleagues in more than 75 markets outside of the U.S
Support for biologics manufacturability and Industry 4.0 initiatives
Crosscope Dx is a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Doctors at Yashoda Hospitals Hyderabad perform rare operation
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
